Loading...
Longevity Health Holdings Inc.
XAGE•NASDAQ
Healthcare
Biotechnology
$3.88
$-0.18(-4.43%)
Longevity Health Holdings Inc. (XAGE) Financial Performance & Income Statement Overview
Review Longevity Health Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
4.19%
↑ 4.19%
Net Income Growth
32.87%
↑ 32.87%
Operating Cash Flow Growth
47.43%
↑ 47.43%
Operating Margin
-914.07%
↓ 914.07%
Gross Margin
55.97%
↑ 55.97%
Net Profit Margin
-1534.44%
↓ 1534.44%
ROE
246.61%
↑ 246.61%
ROIC
157.12%
↑ 157.12%
Longevity Health Holdings Inc. (XAGE) Income Statement & Financial Overview
Review Longevity Health Holdings Inc.'s (XAGE) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $17479.00 | $20519.00 | $12320.00 | $0.00 |
| Cost of Revenue | $1225.00 | $4840.00 | $292.00 | $57570.00 |
| Gross Profit | $16254.00 | $15679.00 | $12028.00 | -$57570.00 |
| Gross Profit Ratio | $0.93 | $0.76 | $0.98 | |
| R&D Expenses | $189018.00 | $331806.00 | $104066.00 | $429420.00 |
| SG&A Expenses | $815666.00 | $1.09M | $1.08M | $893355.00 |
| Operating Expenses | $1.02M | $1.44M | $1.20M | $1.32M |
| Total Costs & Expenses | $1.02M | $1.44M | $1.20M | $1.38M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $7513.00 | $7123.00 | $9345.00 | $25034.00 |
| Depreciation & Amortization | $38539.00 | $42881.00 | $58270.00 | $57570.00 |
| EBITDA | -$965510.00 | -$2.83M | -$3.24M | -$3.47M |
| EBITDA Ratio | -$55.24 | -$137.85 | -$262.74 | |
| Operating Income | -$1.007M | -$1.42M | -$1.19M | -$1.38M |
| Operating Income Ratio | -$57.60 | -$69.19 | -$96.71 | |
| Other Income/Expenses (Net) | -$4685.00 | -$1.46M | -$2.11M | -$2.17M |
| Income Before Tax | -$1.01M | -$2.88M | -$3.30M | -$3.55M |
| Income Before Tax Ratio | -$57.87 | -$140.28 | -$268.23 | |
| Income Tax Expense | -$97279.00 | $0.00 | $0.00 | $1.25M |
| Net Income | -$914283.00 | -$2.88M | -$3.30M | -$4.81M |
| Net Income Ratio | -$52.31 | -$140.28 | -$268.23 | |
| EPS | -$0.04 | -$0.14 | -$0.16 | -$0.21 |
| Diluted EPS | -$0.04 | -$0.14 | -$0.16 | -$0.21 |
| Weighted Avg Shares Outstanding | $20.91M | $20.91M | $20.74M | $22.92M |
| Weighted Avg Shares Outstanding (Diluted) | $20.91M | $20.91M | $20.74M | $22.92M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan